기침 및 감기약 시장 보고서(2026년)
Cough And Cold Preparations Global Market Report 2026
상품코드 : 1951663
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,777,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,796,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,815,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

기침 및 감기약 시장 규모는 최근 꾸준히 확대하고 있습니다. 2025년 880억 7,000만 달러에서 2026년에는 913억 8,000만 달러로, CAGR 3.8%로 성장할 것으로 예상됩니다. 지난 몇 년간의 성장 요인은 계절성 독감 및 감기 유행 증가, 일반의약품 판매 확대, 호흡기 건강에 대한 인식 개선, 소매 약국 네트워크 확대, 복합형 기침 및 감기약의 보급 등이 꼽힙니다.

기침·감기약 시장 규모는 향후 몇 년간 꾸준한 성장이 전망됩니다. 2030년에는 1,098억 8,000만 달러에 달하고, CAGR은 4.7%가 될 전망입니다. 예측 기간 동안 성장 요인으로는 표적 항바이러스제 개발, 맞춤형 의료 접근법 도입, 허브 요법 및 자연 요법의 통합, 즉각적인 증상 완화에 대한 수요 증가, 온라인 약국 채널의 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 신규 항바이러스제제, 맞춤형 감기 및 기침 치료, 허브 및 자연요법의 통합, 복합 약물 요법, 즉각적인 증상 완화 등이 있습니다.

알레르기 질환의 증가 추세는 예측 기간 동안 기침 및 감기약 시장의 성장을 촉진할 것으로 예상됩니다. 꽃가루, 먼지, 곰팡이, 애완동물 등으로 인한 호흡기 알레르기는 오염된 실내외 공기로 인해 발생합니다. 기침 및 기타 호흡기 증상을 자주 유발하는 이러한 알레르기를 관리하기 위해 기침 및 감기약이 일반적으로 사용됩니다. 예를 들어, 유럽의 임상의와 연구자들을 위한 비영리 단체인 유럽 알레르기 및 임상면역학회(EACAI)는 2025년까지 유럽연합(EU) 인구 3명 중 1명이 알레르기의 영향을 받을 것으로 예측하고 있습니다. 따라서 호흡기 알레르기 유병률 증가는 기침 및 감기약에 대한 수요를 증가시켜 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.

고령화 사회의 진전도 기침-감기약 시장 확대를 뒷받침할 것으로 보입니다. 노인이란 65세 이상의 개인을 말하며, 일반적으로 면역력이 약해져 기침, 감기 등 호흡기질환에 걸리기 쉽습니다. 이러한 취약성 증가는 기침 및 감기약에 대한 수요 증가를 촉진합니다. 예를 들어, 2024년 1월 퓨리서치센터가 발표한 보고서에 따르면 2054년까지 노인 인구는 0.5% 증가할 것으로 예측하고 있습니다. 따라서 노인 인구의 증가는 기침 및 감기약 시장의 성장에 기여하고 있다고 할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSM
영문 목차

영문목차

Cold and cough preparations are medications used to treat symptoms of cold and cough. These drugs work by targeting the receptors to which the virus attaches, antagonizing their action to eliminate the viral infection. This process helps reduce congestion by breaking down mucus and dilating the bronchioles that have been constricted due to mucus buildup.

The main types of drugs in cold and cough preparations include antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. Antihistamines are compounds that block the physiological effects of histamine and are primarily used to treat allergies. Other types include bronchodilators, anticholinergics, and pulmonary antihypertensives. These medications are available in various dosage forms, such as oral syrups, tablets or pills, nasal drops, lozenges, and more, and are distributed through hospital pharmacies, retail pharmacies, and drug stores.

Tariffs have influenced the cough and cold preparations market by raising the cost of imported active pharmaceutical ingredients and packaging materials, impacting production and pricing across global markets. The segments most affected include oral syrups, tablets, and nasal drops, particularly in regions like Asia-Pacific and Europe where manufacturing and import dependencies are high. While costs have increased for manufacturers, tariffs have also encouraged local production and sourcing diversification, potentially accelerating innovation in drug formulations and cost-optimized solutions for consumers.

The cough and cold preparations market research report is one of a series of new reports from The Business Research Company that provides cough and cold preparations market statistics, including cough and cold preparations industry global market size, regional shares, competitors with a cough and cold preparations market share, detailed cough and cold preparations market segments, market trends and opportunities, and any further data you may need to thrive in the cough and cold preparations industry. This cough and cold preparations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cough and cold preparations market size has grown steadily in recent years. It will grow from $88.07 billion in 2025 to $91.38 billion in 2026 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to increasing prevalence of seasonal flu and common cold, growth in over-the-counter drug sales, rising awareness about respiratory health, expansion of retail pharmacy networks, availability of combination cold and cough medications.

The cough and cold preparations market size is expected to see steady growth in the next few years. It will grow to $109.88 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to development of targeted antiviral drugs, adoption of personalized medicine approaches, integration of herbal and natural therapies, increasing demand for fast-acting symptom relief, expansion of online pharmacy channels. Major trends in the forecast period include novel antiviral formulations, personalized cold & cough therapies, herbal & natural remedies integration, combination drug therapies, rapid-acting symptomatic relief.

The rising incidence of allergies is expected to drive growth in the cough and cold preparations market over the forecast period. Respiratory allergies, such as those caused by pollen, dust, mold, and pets, result from contaminated indoor and outdoor air. Cough and cold preparations are commonly used to manage these allergies, which often trigger coughs and other respiratory issues. For example, the European Academy of Allergy and Clinical Immunology, a non-profit organization for European clinicians and researchers, projects that by 2025, 1 in every 3 people in the European Union will be affected by allergies. Consequently, the increasing prevalence of respiratory allergies is expected to boost demand for cough and cold preparations, positively influencing market growth.

The growing geriatric population is also expected to support the expansion of the cough and cold preparations market. The geriatric population refers to individuals aged 65 and older, who generally have weaker immune systems, making them more susceptible to respiratory infections like coughs and colds. This increased vulnerability drives greater demand for cough and cold remedies. For example, in January 2024, the Pew Research Center reported that the geriatric population is projected to increase by 0.5% by 2054. Therefore, the rising number of elderly individuals is contributing to the growth of the cough and cold preparations market.

Key players in the cough and cold preparations market are introducing new products, such as clean over-the-counter (OTC) medicines for children, to meet rising consumer demand for safer, natural, and effective remedies. Clean OTC kids' medicines are non-prescription formulations designed specifically for children, emphasizing natural ingredients and minimal additives. These products aim to relieve common cold and cough symptoms while avoiding harmful substances, appealing to parents seeking safer options. For instance, in September 2023, Genexa, a US-based pharmaceutical company, launched two clean OTC products: Kids' Multi-Symptom Cold and Flu, and the Kids Daytime Nighttime Cough Relief Value Pack. The Multi-Symptom Cold and Flu formulation temporarily controls cough, reduces fever, and alleviates minor aches without artificial ingredients. The Daytime and Nighttime Cough Relief Value Pack provides non-drowsy relief during the day and comfort at night, offering comprehensive symptom management for children.

Major companies operating in the cough and cold preparations market are Johnson & Johnson, GlaxoSmithKline plc, Procter & Gamble, Bayer AG, Reckitt Benckiser Group plc, Novartis AG, Perrigo Company, Sun Pharmaceutical Industries Ltd., Prestige Consumer Healthcare, Blackmores Limited, AFT Pharmaceuticals, Dexa Medica, Glenmark Pharmaceuticals Limited, Wockhardt Ltd, Apnar Pharma LP, Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, KYORIN Holdings Inc, Nichi-Iko Pharmaceutical Co. Ltd, Otsuka Pharmaceutical Co. Ltd, China National Pharmaceutical Group Co. Ltd, Shanghai Anovent Pharma, Shanghai Acebright Pharmaceuticals Group Co. Ltd, China Meheco Group Co. Ltd, Merck & Co, Abbott Laboratories, Boehringer Ingelheim, Vectura Group, Pfizer, Mylan, Teva Pharmaceutical Industries Ltd, Sanofi, W. K. Buckley Limited, BENYLIN, Sanfer, PROBIOMED, PiSA, EMS Pharma, Hypermarcas, Ache, Eurofarma, Biolab Farmaceuticad, Cristalia, Libbs, AstraZeneca, Neopharma, Regal Pharmaceuticals, Adcock Ingram, Aspen Pharmacare

North America was the largest region in the cold and cough preparation market share in 2025. Middle East is expected to be the fastest-growing region in the global cough and cold preparations market during the forecast period. The regions covered in the cough and cold preparations market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cough and cold preparations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold and cough preparations market consists of sales of dextromethorphan, guaifenesin, and phenylephrine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cough And Cold Preparations Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cough and cold preparations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cough and cold preparations ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cough and cold preparations market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Cough And Cold Preparations Market Characteristics

3. Cough And Cold Preparations Market Supply Chain Analysis

4. Global Cough And Cold Preparations Market Trends And Strategies

5. Cough And Cold Preparations Market Analysis Of End Use Industries

6. Cough And Cold Preparations Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cough And Cold Preparations Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Cough And Cold Preparations Total Addressable Market (TAM) Analysis for the Market

9. Cough And Cold Preparations Market Segmentation

10. Cough And Cold Preparations Market Regional And Country Analysis

11. Asia-Pacific Cough And Cold Preparations Market

12. China Cough And Cold Preparations Market

13. India Cough And Cold Preparations Market

14. Japan Cough And Cold Preparations Market

15. Australia Cough And Cold Preparations Market

16. Indonesia Cough And Cold Preparations Market

17. South Korea Cough And Cold Preparations Market

18. Taiwan Cough And Cold Preparations Market

19. South East Asia Cough And Cold Preparations Market

20. Western Europe Cough And Cold Preparations Market

21. UK Cough And Cold Preparations Market

22. Germany Cough And Cold Preparations Market

23. France Cough And Cold Preparations Market

24. Italy Cough And Cold Preparations Market

25. Spain Cough And Cold Preparations Market

26. Eastern Europe Cough And Cold Preparations Market

27. Russia Cough And Cold Preparations Market

28. North America Cough And Cold Preparations Market

29. USA Cough And Cold Preparations Market

30. Canada Cough And Cold Preparations Market

31. South America Cough And Cold Preparations Market

32. Brazil Cough And Cold Preparations Market

33. Middle East Cough And Cold Preparations Market

34. Africa Cough And Cold Preparations Market

35. Cough And Cold Preparations Market Regulatory and Investment Landscape

36. Cough And Cold Preparations Market Competitive Landscape And Company Profiles

37. Cough And Cold Preparations Market Other Major And Innovative Companies

38. Global Cough And Cold Preparations Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cough And Cold Preparations Market

40. Cough And Cold Preparations Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기